NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
* Return to Hepatitis Alert Section

Study data from G. Bedogni and co-authors update knowledge of hepatitis B virus



December 8th, 2008

   2008 DEC 8 -- According to a study from Modena, Italy, "Population-based studies of the natural course of chronic viral liver disease that consider comorbidity factors are lacking. Using data from the Dionysos Study, we quantified the burden of chronic viral liver disease and the role of alcohol intake to morbidity and mortality in a representative sample of subjects from the general population of two communities of Northern Italy."

   "AND FINDINGS: We followed up 139 subjects with chronic hepatitis C virus (HCV) infection and 61 with chronic hepatitis B virus (HBV) infection for a median (IQR) time of 8.4 (1.0) and 8.3 (0.9) yr, respectively. Ethanol intake was evaluated using a food-frequency questionnaire, fatty liver (FL) was diagnosed by ultrasonography, and liver cirrhosis (LC) and hepatocarcinoma (HCC) were diagnosed by liver biopsy. Exact multivariable Poisson regression was performed to identify predictors of death. The incidence and remission rates of FL were 9.0 and 29.7 in the HCV cohort and 4.0 and 30.4 per 1,000 person-years (PY) in the HBV cohort. Progression to LC and HCC was more common in the HCV than in the HBV cohort (4.5 vs 2.0 and 2.7 vs 2.0 per 1,000 PY, respectively). Ethanol intake was an independent predictor of LC in the HCV cohort [rate ratio (RR) = 4.15 (95% Cl 1.02-41.2) for every increase of 30 g/day of ethanol intake at baseline] and of death rate in both cohorts [RR = 8.53 (95% Cl 1.40-24.61) and 3.56 (1.34 to 26.50) for every increase of 30 g/day of ethanol intake at baseline]. The morbidity and mortality rate of HBV and HCV infection in the general population is lower than that reported in secondary-care populations, blood donors, or clinical series," wrote G. Bedogni and colleagues.

   The researchers concluded: "Ethanol intake is an independent predictor of LC in subjects with chronic HCV infection and an independent predictor of death in subjects with either HCV or HBV infection."

   Bedogni and colleagues published their study in American Journal of Gastroenterology (Natural Course of Chronic HCV and HBV Infection and Role of Alcohol in the General Population: The Dionysos Study. American Journal of Gastroenterology, 2008;103(9):2248-2253).

   For more information, contact S. Bellentani, Osped Carpi, Azienda USL Modena, Ambulatorio Gastroenterology & Center Studi Nutrition & Fega, Via Molinari 2, I-41012 Modena, Italy.

   Publisher contact information for the American Journal of Gastroenterology is: Blackwell Publishing, 9600 Garsington Rd., Oxford OX4 2DQ, Oxon, England.

   Keywords: Italy, Modena, Biopsy, Chronic Hepatitis B, Chronic Hepatitis C, Fatty Liver, Fibrosis, Gastroenterology, HBV, HCV, Hepatitis B Virus, Hepatitis C Virus, Hepatocellular Cancer, Hepatocellular Carcinoma, Hepatology, Infectious Disease, Liver Cirrhosis, Liver Disease, Oncology, Surgery, Virology.

   This article was prepared by Clinical Oncology Week editors from staff and other reports. Copyright 2008, Clinical Oncology Week via NewsRx.com.

Return to Hepatitis Alert Section

NewsRx Passes
Advertisement
------------------------
Security by Verisign PR Login